A supportive seasonal allergic rhinitis (sar) trial showed

Significant improvement

vs products your patients may have tried

DYMISTA® demonstrated significantly greater improvement in total nasal symptom relief vs ASTELIN® (azelastine HCI) or generic FLONASE® (fluticasone propionate) in patients 12 years and older.1,2

Graph of Dymista (azelastine hydrochloride and fluticasone propionate) comparison to generic Astelin and generic Flonase, described as below.

Study design

Change from baseline in the placebo-subtracted mean rTNSS for each day (maximum score 24), averaged over the 14-day study period.2

Percent difference represents the improvement in rTNSS with DYMISTA relative to commercially available ASTELIN or generic FLONASE comparators.1,2

References: 1. Data on file. Meda Pharmaceuticals Inc., a Viatris Company. 2. Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105(2):168-173.